PhRMA Aims To Clarify Use Of AERS Signals Through Data Mining Studies

While all sources of reports to FDA's Adverse Event Reporting System make significant contributions to signal detection, foreign sources appear to be one of the strongest contributors, preliminary results from a PhRMA-sponsored study of the database suggest